Morphogenesis Inc. | WebDisclosure

Switch to English

8295	Sociétés
114831	Mots-clés
55272	Articles
62429	Communiqués

Accueil
Sociétés
Morphogenesis Inc.

BRÈVE

publiée le 25/04/2024 à 15:05, il y a 6 mois 25 jours

TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
BRÈVE

publiée le 25/04/2024 à 15:05, il y a 6 mois 25 jours

TuHURA Biosciences présentera les résultats des essais cliniques à l'ASCO 2024

TuHURA Biosciences Essais Cliniques Fusions Et Acquisitions ASCO 2024 Immunothérapie Anticancéreuse
COMMUNIQUÉ DE PRESSE

publié le 25/04/2024 à 15:00, il y a 6 mois 25 jours

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs

Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
COMMUNIQUÉ DE PRESSE

publié le 14/12/2023 à 16:00, il y a 11 mois 6 jours

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview
COMMUNIQUÉ DE PRESSE

publié le 08/11/2023 à 15:00, il y a 1 année

Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

Les Echos

Publié le 21/11/2024 à 06:58, il y a 3 heures 41 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 41 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 41 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 14 heures 31 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 15 heures 19 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 10:03, il y a 36 minutes

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Publié le 21/11/2024 à 10:00, il y a 39 minutes

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Publié le 21/11/2024 à 09:00, il y a 1 heure 39 minutes

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Publié le 21/11/2024 à 00:35, il y a 10 heures 4 minutes

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Publié le 21/11/2024 à 00:25, il y a 10 heures 14 minutes

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 10:04, il y a 34 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:02, il y a 36 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:00, il y a 38 minutes

Nabaltec AG continues solid earnings performance in third quarter of 2024
Publié le 21/11/2024 à 10:00, il y a 39 minutes

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Publié le 21/11/2024 à 09:41, il y a 57 minutes

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy